KABRINA WILSON: Open Payments
NPI 1043681109 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$263 in 13 payments from 9 companies in 2025. Trend: 2023 $367 · 2024 $0 · 2025 $263
Food & beverage: $263
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| Lundbeck LLC | 2 | $53 |
| Lilly USA, LLC | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Tris Pharma Inc | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| TMS NeuroHealth Centers Inc. | 1 | $16 |
Products named: REXULTI, CAPLYTA, VOQUEZNA, Dyanavel XR, XIFAXAN, HETLIOZ, MOUNJARO, TMS NeuroHealth Centers Inc..
Industry payments across MD — which companies pay providers there.
